Загрузка...
Effect of the Glucagon‐like Peptide‐1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus
BACKGROUND: Exenatide extended release (ER) is a glucagon‐like peptide‐1 analogue that increases insulin secretion, inhibits glucagon secretion and induces satiation in humans with type 2 diabetes mellitus. The use of exenatide ER is safe and stimulates insulin secretion in healthy cats. OBJECTIVES:...
Сохранить в:
| Опубликовано в: : | J Vet Intern Med |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4913624/ https://ncbi.nlm.nih.gov/pubmed/26700409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.13817 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|